Evolving testing and therapeutic landscapes surrounding PNH.
Rare diseases, such as paroxysmal nocturnal hemoglobinuria (PNH), present a clinical challenge given the difficulty of diagnosing and effectively treating patients. Approximately 7,000 disorders have been classified as ‘rare’ to date, with many patients left undiagnosed due to the complexity of symptoms and presentation of these disorders.
Download this whitepaper to learn about the evolving testing and therapeutic landscapes surrounding PNH, which, like other rare diseases, requires early diagnosis for better management and improved outcomes.
Offered Free by: NeoGenomics
See All Resources from: NeoGenomics